Tetrahydrofuran → 2-(4-Hydroxy-2,2,6,6-tetramethyl-piperidin-1-yl)-1,3-di-p-tolyl-isourea
반응식
[CH3:1][C:2]1([CH3:12])[N:7]([O])[C:6]([CH3:10])([CH3:9])[CH2:5][CH:4]([OH:11])[CH2:3]1.[H][H].[C:15]1([CH3:31])[CH:20]=[CH:19][C:18]([N:21]=[C:22]=[N:23][C:24]2[CH:29]=[CH:28][C:27]([CH3:30])=[CH:26][CH:25]=2)=[CH:17][CH:16]=1.C1C[O:35]CC1>>[OH:11][CH:4]1[CH2:3][C:2]([CH3:12])([CH3:1])[N:7]([O:35][C:22](=[N:23][C:24]2[CH:25]=[CH:26][C:27]([CH3:30])=[CH:28][CH:29]=2)[NH:21][C:18]2[CH:19]=[CH:20][C:15]([CH3:31])=[CH:16][CH:17]=2)[C:6]([CH3:10])([CH3:9])[CH2:5]1참가 물질
5
실험 절차
4-Hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (1.9 g, 11 mmol) is dissolved in THF (40 ml) and hydrogenated in the presence of 0.035 g Pt (5% on carbon) catalyst using 4 bar hydrogen pressure. The hydrogen uptake stops after approximately one hour. The reaction mixture is then filtered and mixed with the solution of bis-p-tolyl-carbodiimide (2.45 g, 11 mmol) in THF (30 ml). The solution is stirred under argon at room temperature for 16 hours and concentrated. The residue is chromatographed on silica gel with hexane-ethyl acetate (1:1) and the pure fractions are crystallized from ethyl acetate to afford 1.6 g of the title compound as a colorless solid, mp. 124-126° C.
후처리
- filtrationThe reaction mixture is then filtered
- concentrationconcentrated
- customThe residue is chromatographed on silica gel with hexane-ethyl acetate (1:1)
- customthe pure fractions are crystallized from ethyl acetate
출처 및 근거
- ORD 기록
- ord-4fe92e9146c04b1e88aafceca9fb7863
- 출처 데이터셋
- uspto-grants-2014_03
- 특허 번호
- US08669398B2
반응 노트
불러오는 중…